Oncology Congress 2025

Conference Tools

Announcing the 4th International Conference on Cancer and Oncology Research!
Date: October 20–21, 2025
Location: Dubai, UAE

With the support of dedicated academicians and a passionate organizing committee, we are thrilled to invite you to join us for this transformative event under the theme: "Research Trends and Technological Innovations in Cancer." Together, we will advance the fight against cancer by fostering meaningful exchanges of groundbreaking scientific discussions, pioneering research, and cutting-edge advancements in cancer treatment and prevention.

This gathering unites leading experts—top delegates, renowned scientists, innovative researchers, esteemed scholars, and dedicated medical professionals—who share a commitment to driving forward change and improving patient outcomes worldwide. Through impactful presentations and insightful demonstrations, this congress promises to be an engaging platform for sharing knowledge, igniting ideas, and inspiring new directions in cancer research.

"Join us in this powerful movement to explore the frontiers of cancer research and innovation. Let’s drive forward together, advancing the breakthroughs that bring us closer to a cancer-free future."

Develop a Global Network: Forge connections that drive development and open doors.
Connect, Share, and Learn: Engage with experts across diverse fields.
Showcase Your Work: Present your ideas and research to a global audience.
Build New Collaborations: Collaborate with professionals and researchers from around the world.
Expand Your Knowledge: Dive into the latest advancements in hematology and beyond.
Explore Beyond Your Field: Discover insights that broaden your perspective.
Gain a Competitive Edge: Enhance your expertise with valuable knowledge and connections.
Authentic Networking: Experience real, impactful networking that lasts.

Read More

Abstract Submissions are
open for Oral/Poster Presentations

Early Bird Registration ends on
31^st -January-2025

First Call Registration ends on
15^th -April-2025

Late Bird Registration ends on
15^th -Augsut-2025

Mohamed El-Far

Mansoura University

Egypt

Kostas Syrigos

University of Athens

Greece

Prachi Upadhyay

SRMS IM

India

Hamza Khan

Croydon Hospita

UK

Mikeladze Khatia

Iv. Javakhishvili Tbilisi State University

Georgia

Duygu Abbasoglu

Centre Jean Perrin

France

Hamza Khan

CROYDON HOSPITAL

Rocío del Campo-Pedrosa

Encore Lab S.L

Spain

Oncology Research - Scopus Indexed

ncology Research is committed to publishing high-quality, innovative research that is focused on the entire range of basic, translational, and clinical cancer research, with a particular interest in cancer therapeutics.

Specific areas of interest include but are not limited to: identification of potential targets for cancers and the exploration of novel molecular mechanisms of tumorigenesis and metastasis; development of novel small molecules and targeted therapies;mechanisms of drug sensitivity; mechanisms of cellular drug resistance; biomarkers of response and/or resistance; novel experimental model systems and technologies relating to cancer therapeutics; pharmacogenetics and pharmacogenomics; personalized medicine; cancer stem cell; immunotherapy and clinical immunology; gene therapy; and radiobiology and novel approaches to radiation therapy either alone or in combination with chemotherapy. For studies that investigate the role of non-coding RNAs as regulators of cellular gene expression, it will be important for more in-depth mechanistic studies to be conducted that confirm their biological activity and their potential effect as mediators of chemosensitivity. The journal also embraces preclinical studies that are focused on drug design, chemical biology, and drug screening. In addition, submissions that investigate the potential role of herbal/botanical medicines in preclinical and clinical cancer therapy are welcomed; however, it will be important to document that these medicines are of high quality, with confirmation of batch-to-batch consistency. In addition to original peer-reviewed articles, the journal also welcomes timely reviews, case reports, editorials, analyses, letters and other types of manuscripts.

Dubai, UAE

KNOW MORE

Day-1
October 20, 2025
Day-2
October 21, 2025

09:00 - 10:00

Registration and Welcome Ceremony

Welcome to all attendees, confirming their presence with an opening speech and inaugural ceremony. Announcements of participating companies, universities, societies, exhibitors, and collaborators to mark the successful start of the conference.

10:00 - 10:45

Keynote Presentations

The conference opens with keynote presentations by esteemed speakers who will set the stage with their insights and expertise, sparking enthusiasm for the event.

10:45 - 11:00

Refreshment Break

A short break to refresh with tea, coffee, and an assortment of snacks, helping attendees recharge for the sessions ahead.

11:00 - 13:00

Conference Sessions

Presentations from key speakers covering conference highlights, addressing all attendees.

13:00 - 14:00

Lunch

A lunch break featuring an array of international cuisine, providing attendees a chance to recharge and network informally.

14:00 - 16:00

Conference Sessions

Afternoon session presentations, featuring in-depth discussions on pivotal conference themes.

16:00 - 16:30

Refreshment Break

A chance to recharge with refreshments and light snacks before the final session of the day.

16:30 - 17:00

Panel Discussions

The day concludes with a panel discussion involving keynote speakers and attendees, fostering dialogue, feedback, and insights for future development.

09:00 - 10:00

Registration and Welcome Ceremony

10:00 - 10:45

Keynote Presentations

The conference opens with keynote presentations by esteemed speakers who will set the stage with their insights and expertise, sparking enthusiasm for the event.

10:45 - 11:00

Refreshment Break

A short break to refresh with tea, coffee, and an assortment of snacks, helping attendees recharge for the sessions ahead.

11:00 - 13:00

Conference Sessions

Presentations from key speakers covering conference highlights, addressing all attendees.

13:00 - 14:00

Lunch

A lunch break featuring an array of international cuisine, providing attendees a chance to recharge and network informally.

14:00 - 16:00

Conference Sessions

Afternoon session presentations, featuring in-depth discussions on pivotal conference themes.

16:00 - 16:30

Refreshment Break

A chance to recharge with refreshments and light snacks before the final session of the day.

16:30 - 17:00

Panel Discussions

The day concludes with a panel discussion involving keynote speakers and attendees, fostering dialogue, feedback, and insights for future development

Scisynopsis is proud to announce the tremendous success of the 3rd International Conference on Cancer and Oncology Research, scheduled to take place in Barcelona, Spain, on November 11-12, 2024. The conference, under the theme "Raising Wings to Promote a Cancer-Free World,". We sincerely thank the renowned scientists, distinguished researchers from different universities, research institutes, companies, laboratories with the latest knowledge on topics related to Cancer and Oncology Research. The conference was remarked with huge success followed by Keynote Sessions, followed by Oral presentations, poster presentations video presentations. The highlights of the meetings are presented by

Hamza Khan, Croydon Hospital, United Kingdom
Prachi Upadhyay, SRMS IMS, India
Erkan Vardareli, Acibadem MAA University, Turkey
Shahriar Tarighi, Max Planck Institute for Heart and Lung Research, Germany
Prabhancha Prabhakumar Nair, Hull University Teaching Hospitals NHS Trust, United Kingdom
Chuanxi Lai, Zhejiang University, China
Gautham Vinayak Gopikuttan Nair, Hull University Teaching Hospitals NHS Trust, United Kingdom
Duygu Abbasoglu, Centre Jean Perrin, France
Dalia Albaik, Hull University Teaching Hospital, United Kingdom
Dalia Ghalwash, The British University in Egypt, Egypt
Fathia Zahran, Cairo University, Egypt
Raha West, Imperial College London, United Kingdom
Joao Guerra, ULS São José, Portugal
Khatia Mikeladze, Iv. Javakhishvili Tbilisi State University, Georgia
Rocío del Campo-Pedrosa, Encore Lab SL, Spain
Diana Hennessey, Universidad El Bosque, Colombia
Shanees Nazeer, Univerisity of Manchester, United Kingdom
Benoit Debruyne, Maison Médicale Univers Santé, Belgium
Jack Bannister, University of Manchester, United Kingdom
Beatrice Schuler-Thurner, University Hospital Erlangen, Germany
Agnes Aas, Tallinn University, Estonia
Valentina De Falco, Institute of Endocrinology and Experimental Oncology (IEOS), National Research Council (CNR), Italy
Habil. Bernd Blobel, University of Regensburg, Germany
Camilla Palumbo, University of Rome "Tor Vergata", Italy
Santosh Kumar Mishra, Women’s University, India
Yuri Hirayama, University Hospitals Birmingham NHS Foundation Trust, United Kingdom
Frelet-Barrand A, Bourgogne Franche-Comte University, France
Loai Abdallah, The Max Stern Yezreel Valley College, Israel
Moatasem Zaaroura, The Max Stern Yezreel Valley College, Israel
Darius BENIMANA, Medcancer initiative, Rwanda
Jung Su Yon, University of California, USA
Snigdha Baddepudi, University Hospital Southampton NHS Foundation Trust, United Kingdom
Mark Knights, Oxford University Hospitals, United Kingdom
Kashmala Gul, Bristol England, United Kingdom

We would like to extend our heartfelt gratitude to our esteemed Session Chairs: Prachi Upadhyay, Duygu Abbasoglu, and Raha West, whose dedication and expertise were integral to the success of our conference.

A special thank you to our Moderator, Shahriar Tarighi, for his invaluable support in guiding our discussions throughout the event.

We are pleased to announce the Best Oral Presentation award goes to Shahriar Tarighi from the Max Planck Institute for Heart and Lung Research, Germany.

The Best Poster Presentation awards are presented to Duygu Abbasoglu from Centre Jean Perrin, France, and Hamza Khan from Croydon Hospital, United Kingdom. Congratulations to all!

We are incredibly grateful to all our attendees for sharing their cutting-edge research and for their active participation, which made this conference such a success.

Building on the momentum of the Oncology Congress 2024 this November, we are excited to announce the 4th International Conference on Cancer and Oncology Research will take place on October 20-21, 2025, in Dubai, UAE.

For more information, please visit: https://scisynopsisconferences.com/oncology/

We look forward to meeting you in Dubai!

Thank you.

Scisynopsis is happy to announce that it successfully completed “2^nd International Conference on Cancer and Oncology Research” held on April 15-16, 2024, at London, UK, with the theme “Raising Wings to Promote Cancer Free World” with great success. We sincerely thank the renowned scientists, distinguished researchers from different universities, research institutes, companies, laboratories with the latest knowledge on topics related to Cancer and Oncology Research. The conference was remarked with huge success followed by Keynote Sessions, followed by Oral presentations, poster presentations video presentations. The highlights of the meetings are presented by

Krisztina Takacs-Vellai, Eotvos Lorand University, Hungary
Irina Groisman, Institut Gustave Roussy, France
Melissa Rundle, Reprocell, USA
Gordon W Stewart, University College London, United Kingdom
Walid Ibrahim, Princess Royal University Teaching Hospital, United Kingdom
Heena Dalal, Lund University, Sweden
Ahmad Behzadpour, Curbside Health, USA
Ismael Rodriguez, Wydcial Chemii UJ, Poland
Xiaomin Quan, Beijing University of Chinese Medicine, China
Ida De Chiara, Univeristà degli Studi della Campania “Luigi Vanvitelli”, Italy
Ahmed Soliman, East Lancashire Hospitals NHS Trust, United Kingdom
Suzy Ramos Rocha, São Paulo University, Brazil
Maria Teresa Gentile, University of Campania L. Vanvitelli, Italy
Mohammad Kaleem Ahmad, King George’s Medical University, India
Antonia Feola, University of Naples Federico II, Italy
Ilaria Baglivo, University of Campania “Luigi Vanvitelli”, Italy
MJ Ndlovu, University of Limpopo, South Africa
Rafael Campos Silva, Federal University of Maranhão, Brazil
Bene Ekine-Afolabi, ZEAB Therapeutic Ltd, United Kingdom
Sara Petrosino, TIGEM, Italy
Benjamin Ziman, University of Southern California, USA
Amir Hossein Emami, Tehran University of Medical Sciences, Iran
Sophie Grigolo, University of Fribourg, Switzerland
Paola Della Monica, University of Naples “Federico II”, Italy
Noel Christian Alitre, West Visayas State University, Philippines
Ugo Rovigatti, University of Florence, Italy
Yihao Huang, Guangdong Country Garden School, China
Valentina De Falco, Institute of Endocrinology and Experimental Oncology (IEOS), Italy
Anastasia Shumeikina, Meshalkin National Medical Research Center, Russia
Lujain Alsahman, King Saud University, Saudi Arabia
Jonathan C M Wan, IMT2 Acute Medicine, University College London Hospital, UK
Frederick H. Silver, OptoVibronex, USA
WenQing Yang, ClinBridge Biotech Inc Ltd, China
Mi Hyang Hwang, Dongguk University, South korea
Thamizholi Selvaraju, Assam Cancer Care Foundation, India
Aneri Joshi, Nirma University, India
Nkemehule F.E., University of Lagos, Nigeria
Basma Rajab, Kings College, United Kingdom
Francisco Medrano, Salud integral Hospital, USA
Sofia Chaniotaki, General Hospital of Athens, Greece

We would like to thank our Session chairs: Krisztina Takacs-Vellai, Irina Groisman, Maria Teresa Gentile and Bene Ekine-Afolabi & who supported us for the conference.
We once again thankful to our all our attendees who presented their valuable work in the conference and supported us.

Best Oral Presentation goes to Heena Dalal, Lund University, Sweden

Best Poster Presentation goes to Sophie Grigolo, University of Fribourg, Switzerland

Proceeding with the success of Oncology Congress 2024, we are glad to announce the upcoming event 3^rd International Conference on Cancer and Oncology Research scheduled on November 11-12, 2024, in Barcelona Spain.

For more info, please visit: https://scisynopsisconferences.com/oncology/

Wish to meet you in Barcelona Spain.
Thank you.

Scisynopsis is happy to announce that it successfully completed “International Conference on Cancer and Oncology Reearch” held on June 19-20, 2023 at Rome,Italy, with the theme “Raising Wings to Beat Cancer Free World” with great success. We sincerely thank the renowned scientists, distinguished researchers from different universities, research institutes, companies, laboratories with the latest knowledge on topics related to Cancer and Oncology Research. The conference was remarked with huge success followed by Keynote Sessions, followed by Oral presentations, poster presentations video presentations. The highlights of the meetings are presented by:

Gradimir Dimitrijevic, Institute for Blood Transfusion,Serbia
Ivan P. Gorlov and Olga Y. Gorlova, Baylor College of Medicine,USA
Lucia Mundo, University of Limerick, Ireland
Maria Teresa Gentile, University of Campania “L.Vanvitelli”,Italy
Emmanuel A. Babington, University Hospitals of Leicester NHS Trust, United Kingdom
Revital Azulay, Meuhedet Health Fund, Israel
Daniela Vargová, Comenius University, Slovakia
Maria Pelullo, Sapienza University, Italy
Irina Groisman, Institut Gustave Roussy, France
Silvia Belluti, University of Modena and Reggio Emilia, Italy
Ehsan Pourkarimi, Hamad Bin Khalifa University, Qatar
Saule Balmagambetova, West Kazakhstan Marat Ospanov Medical University, Kazakhstan
Ugo Rovigatti, University of Florence, Italy
Suresh Alahari, LSU Health New Orleans, USA
Nauf Bou Antoun, Kingston University London, United Kingdom
Heer Shah, University of Oxford, United Kingdom
Aléxia Thamara Gasparin, Hilab, Brazil
Donatella Romaniello, Alma Mater Studiorum University of Bologna, Italy
Gabriel Pasquarelli do Nascimento, University of Brasilia, Brazil
Markus Bredel, University of Alabama, USAAngela Pallangyo,Kilimanjaro Christian Medical University College, Tanzania
Chilaca Rosas María Fátima, National Medical Cancer Center siglo XXI, Mexico/ National Autonomous University of Mexico
Jedrzej Antosiewicz and Ulana Juhas, Medical University of Gdańsk, Poland
Klaudia Zuczek, University of Gdańsk, Poland
Anna Herman-Antosiewicz, University of Gdańsk, Poland
Zhenisgul Tlegenova, West Kazakhstan Marat Ospanov Medical University, Kazakhstan
Rabah Iratni, United Arab Emirates University, UAE
Yun-Ju Chen, I-Shou University, Taiwan
Yueh-Ming Lin, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taiwan
Agnieszka Pyrczak-Felczykowska, Medical University of Gdańsk, Poland
Mariola Gimla, University of Gdańsk, Poland
WenQing Yang, Founder and Chief Scientific Officer, Clin-Bridge Biotech Ltd., China
Camilla Palumbo, University of Rome ‘Tor Vergata’, Italy
Ahmed Elzawahry, Gateshead Health NHS Foundation Trust,United Kingdom
Maria Magdalena Barreca, University Of Palermo, Italy
Evdokimova Sevindzh P, Hertsen Moscow Oncology Research Institute, Russia
Patrycja Czerwinska, Greater Poland Cancer Centre, Poland
Marzia Pucci, University of Palermo, Italy
Jassim Zaheen Shah, Qatar University, Qatar
Marwah Suliman Maashi, King Abdulaziz University, Saudi Arabia
Seema Devi, IGIMS, India
Brou Richmond Konan, University Felix Houphouet-Boigny Abidjan, Cote d’Ivoire
Syrine Ben Dhia, Antoine Lacassagne Center, France
Loai Abdallah, The Max Stern Yezreel Valley College, Israel
Howard Bruckner, MZB Foundation for Cancer Research, USA
Hannah Riva, Texas Tech University Health Sciences Center, USA
Małgorzata Drzewiecka, Uniwersytet Łódzki, Poland
Alireza Khosravani, Royan Institute, Iran
Jane Kinuthia, Academic model providing access to health care-AMPATH, Kenya
Krisztina Takacs-Vellai, Eötvös Lorand University, Hungary
Trivikram Madhusoodan Deshpande and Hanmantrao D. Kanase, Kisan Veer Mahavidyalaya, India
Hamed Hosseinalizadeh, Guilan University of Medical Sciences, Iran
Mxolisi Justice Ndlovu, University of Limpopo, South Africa
Ashu Chaudhary, Kurukshetra University, India
Fatemeh Ghaemi, Royan Institute, Iran
Subhash, Kurukshetra University, India
Soroor Eslahi, Royan Institute, Iran
Faizan Fazal, Rawalpindi Medical University, Pakistan
Parisa Shams, Royan Institute, Iran
Mohite Utkarsha Laxman, MET’s League of Colleges, Bhujbal Knowledge City, India
Delbar Daneshjou, Kian Immune Cell Co., Iran
Yuwei Cheng, Cleveland Clinic, USA
Aslı Elif Tanugur Samancı, Istanbul Medipol University, Istanbul, Turkey
Jingfen Shi, University of Electronic Science and Technology of China, China

We would like to thank our Session chairs: Gradimir Dimitrijevic, Jedrzej Antosiewicz, and Suresh Alahari & who supported us for the conference.
We once again thankful to our all our attendees who presented their valuable work in the conference and supported us.

Proceeding with the success of Oncology Congress 2023, we are glad to announce the upcoming event 2nd International Conference on Cancer and Oncology Research scheduled on April 15-16, 2024 at London, UK.

For more info, please visit: https://scisynopsisconferences.com/oncology/

Wish to meet you at London, UK!!!
Thank you.

Mohamed El-Far

Mansoura University, Egypt

Dear colleagues

It is my pleasure to extend a warm welcome to join our conference under title: 4^th International Conference on Cancer and Oncology Research, to be held on October 20-21 at Dubai, UAE, with the theme (Research Trends and Technological Innovations in Cancer). Conference is set to unite all scientists, academics, oncologists professionals as well as students to convene and exchange insights at cancer research fields and its clinical applications. Besides, innovations and advancements at these various aspects.

The conference agenda will focus on critical topics and aimed the followings:

To discuss several key issues that greatly affect treatments of different types of cancer.
To refocus vision for cancer research innovations in present key challenges in cancer management in different directions as:

New prevention protocols
Novel ways for early detection
Search for more safer effective modalities
promotion of scientific collaboration as well as facilitating knowledge sharing between scientists, medical doctors and companies as a goal of our conference.

As Honourable Chairman we do welcome all of you to join our conference to be a part of shaping a better future in this field.

Oncology 2024

Subscribe To Our Newsletter

Acceptance and Revisions to Terms of Use

By accessing the Scisynopsis conference website you are agreeing to be bound by these terms and conditions of use. If you do not wish to be bound by these terms and conditions, you may not access or use the site. Scisynopsis Conferences have the right to modify these terms at any time and such modifications and changes will be immediately shall be effectively upon updating in this website.

License Restrictions

Subject to compliance with our Terms and conditions, Scisynopsis grants personal, revocable, limited, non-exclusive, non-transferable license to access and the use synopsis conferences websites conditioned with continued acceptance of Terms of Use. Scisynopsis reserve the right to restrict or suspend any user’s access to the websites.

Registration and Payment Methods

Registration and the slot for the final program will only be finalized or confirmed once we receive the payment. We have three modes of registration options:

Online Registration: Registration can be completed from the respective conference website through credit or debit card with international transaction facility through secure online payment gateways. Also, through credit card authorization the online registration can be done.

Offline Registration: For offline registration the user will be provided with the bank account details with their billing details to complete registration through wire transfer. Please quote your invoice number as a reference. The confirmation will be provided once we receive the payment.

Onsite Registration: Registration can be completed at the venue of the conference. The acceptable mode of payment is by cash or through credit card authorization.

Request for Invitation Letter

Invitation letter will be provided to only those who are registered for the conference.

Cancellation Policies

We strictly adhere to our cancellation policies and cancellations should be made in writing.
Scisynopsis have the right to change the policies without any prior notice as last minute changes.
The Organizer holds the sole right to cancel or postpone the conference or webinar in case natural disasters, calamities, terrorism activity, pandemic, unavoidable and unforeseeable circumstances and the same will be intimated to the attendees from the respective program managers.
Organizer will not be responsible for any loss or damage as a result of substitution, alteration, postponement, or cancellation of an event which will be beyond its control including without limitation, force majeure, natural disasters, pandemics, sabotage, accident, trade or industrial disputes, terrorism, or hostilities.
If the conference/webinar is cancelled or postponed due to the cause which will be beyond control of organizer the registrations remain valid for the next future conferences or webinar. The registration and accommodations paid will automatically carry forwarded to the future events. Refund Policies will not be applicable in these cases.
If registrant is unable to attend the next scheduled date of the conference/webinar they will be eligible to get the full paid amount credit which can be used to attend any Scisynopsis conference organized within period of 12 months.
Liability of personal injuries or for loss or damage to property belonging to the delegates, either during, or as a result of the conference/webinar will not be accepted by organizer.

Refund Policies (Conferences, Webinars & Accommodations)

Refund policy will be applicable only when the registrant is eligible to get the refund. Considering the advance payments towards Venue, Printing, Shipping, Hotels, and different overheads, we needed to keep Refund Policy is as following slabs, and all bank charges will be for the registrant's account.
Cancellation before 120 days of the conference: Eligible for Full Refund (with a deduction of 150 USD/150 EURO/150GBP towards administrative/service fee)
Cancellation within 119-90 days of Conference: Eligible for 60% Refund
Cancellation within 89-46 days of Conference: Eligible for 40% Refund
Cancellation within 45 days of Conference: Non-refundable
E-Poster Payments will not be refunded.
The registration with limited costs (special discounts) is transferable to a person or event but not refundable anytime in cash/credit.
In the case of VISA refusal, the paid amount can be transferred to the other conference or can be refunded as per the time policies mentioned above.
Cancellations received no less than 25 days before the scheduled broadcast start time will be eligible for full refund.
Cancellation requests received less than 24th day before the scheduled broadcast start time. Will not be eligible for refund.
Your webinar registration includes access to the live-webinar broadcast only.
All webinars are recorded, and the recordings will be accessible via Pay Per View and the Members' Only Area.
All cancellations or alterations of registration or registrants to be made in writing to Conference Mail ID & accounting@scisynopsis.com

Insurance and Transportation

Insurance is not included in the Registration. Transportation from Airport to hotel completely depends upon the hotel facility. On request we can arrange the transportation for the attendees and the cost will be responsibility of traveler.

When will you Receive your Refund?

The process of refund initiation will take 30-45 working days and through the original mode which the registrant is paid during registration. The processed refund may take up to 9-10 business working days to get reflected in the account or statement.

Responsibility

The attendee will be solely responsible for all their belongings at the venue. Whatever be the reason the organizer will not be responsible for any stolen or missing items of attendees.

Unsolicited Commercial E-Mail (Anti-Spam) Policy

Internet user privacy is of paramount importance to Scisynopsis Conferences and our customers. We support the protection of client and consumers’ privacy rights as a fundamental element of our business.

Message Recipient Policy - Before clients can receive mail from us, advertising, or promotions, the client must have agreed to receive such messages. Any recipient may request at any time to be removed from our list, and we will comply with that request. In addition, we will thoroughly investigate any allegations made by recipients relating to unsolicited messages.

Policy against advertising our website using unsolicited email messages - We require that all e-mails from Scisynopsis Conferences are sent only to clients who have agreed to receive such messages. We prohibit any advertising of our brand and Web site using unsolicited email messages. Not complying with this policy will cause partnership termination and/or affiliate account termination. Unsubscribe any time - We require that each e-mail message sent out from Scisynopsis Conferences includes an easy way for subscribers to remove themselves via an unsubscribe link or by replying to the email with unsubscribe.

If you receive a newsletter or email and decide you don’t like it, simply click the unsubscribe link at the bottom of the email.

Authorization Policy

By registering for the conference you grant permission to Scisynopsis Conferences to portrait, record, and use your name, likeness, image, and comments and to publish, reproduce, exhibit, distribute, broadcast, edit, and/or digitize the ensuing pictures and materials in publications, advertising materials, or in any other form worldwide without compensation. Taking of pictures and/or videotaping throughout any session is prohibited. If not interested with sharing your picture in website for promotion, you can write down in the email.

Contact Us:

For any further queries, you can contact us at below details:

info@scisynopsis.com

contact@scisynopsis.com

Ph. No: +1-770-450-8674,

WhatsApp: +1-770-762-9823,

4th International Conference on

Cancer and Oncology Research

October 20-21, 2025 Dubai, UAE

Conference Information

Conference Tools